Clinical Trial

A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess

Study acronym: CLASS2401
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to train a deep learning-based model to predict multidrug-resistant Klebsiella pneumoniae liver abscess and evaluate it on a multi-center database.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06506318
Lead Sponsor Shengjing Hospital
Collaborators: The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Guilin Medical University, China, Hebei General Hospital, Xijing Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Dalian Medical University, The People's Hospital of Liaoning Province, Fourth People's Hospital of Shenyang, Sir Run Run Shaw Hospital
Conditions Liver Abscess
Enrollment 550 participants
Start Date 2024-01-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-17